162 related articles for article (PubMed ID: 14968413)
1. Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples.
Hesselink AT; van den Brule AJ; Brink AA; Berkhof J; van Kemenade FJ; Verheijen RH; Snijders PJ
Cancer; 2004 Feb; 102(1):11-8. PubMed ID: 14968413
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus (HPV) detection using in situ hybridization in histologic samples: correlations with cytologic changes and polymerase chain reaction HPV detection.
Kelesidis T; Aish L; Steller MA; Aish IS; Shen J; Foukas P; Panayiotides J; Petrikkos G; Karakitsos P; Tsiodras S
Am J Clin Pathol; 2011 Jul; 136(1):119-27. PubMed ID: 21685039
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
4. Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia.
Hesselink AT; van Ham MA; Heideman DA; Groothuismink ZM; Rozendaal L; Berkhof J; van Kemenade FJ; Massuger LA; Melchers WJ; Meijer CJ; Snijders PJ
J Clin Microbiol; 2008 Oct; 46(10):3215-21. PubMed ID: 18685007
[TBL] [Abstract][Full Text] [Related]
5. HPV testing in liquid cytology specimens: comparison of analytic sensitivty and specificity for in situ hybridization and chemiluminescent nucleic acid testing.
Qureshi MN; Bolick D; Ringer PJ; Spagler FL; Zimmerman G
Acta Cytol; 2005; 49(2):120-6. PubMed ID: 15839613
[TBL] [Abstract][Full Text] [Related]
6. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
7. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study.
Gravitt PE; Schiffman M; Solomon D; Wheeler CM; Castle PE
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1248-54. PubMed ID: 18483347
[TBL] [Abstract][Full Text] [Related]
8. Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions.
Birner P; Bachtiary B; Dreier B; Schindl M; Joura EA; Breitenecker G; Oberhuber G
Mod Pathol; 2001 Jul; 14(7):702-9. PubMed ID: 11455003
[TBL] [Abstract][Full Text] [Related]
9. Implications of semi-quantitative HPV viral load estimation by Hybrid capture 2 in colposcopy practice.
Basu P; Muwonge R; Mittal S; Banerjee D; Ghosh I; Panda C; Mandal R; Sankaranarayanan R
J Med Screen; 2016 Jun; 23(2):104-10. PubMed ID: 26566949
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.
Guo M; Gong Y; Deavers M; Silva EG; Jan YJ; Cogdell DE; Luthra R; Lin E; Lai HC; Zhang W; Sneige N
J Clin Microbiol; 2008 Jan; 46(1):274-80. PubMed ID: 17977987
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
12. Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology.
Snijders PJ; Hogewoning CJ; Hesselink AT; Berkhof J; Voorhorst FJ; Bleeker MC; Meijer CJ
Int J Cancer; 2006 Sep; 119(5):1102-7. PubMed ID: 16570279
[TBL] [Abstract][Full Text] [Related]
13. Assessment of fluorescence in situ hybridization and hybrid capture 2 analyses of cervical cytology specimens diagnosed as low grade squamous intraepithelial lesion for the detection of high grade cervical intraepithelial neoplasia.
Voss JS; Kipp BR; Campion MB; Sokolova IA; Henry MR; Halling KC; Clayton AC
Anal Quant Cytol Histol; 2010 Jun; 32(3):121-30. PubMed ID: 20701064
[TBL] [Abstract][Full Text] [Related]
14. Detection of human papillomavirus in cervical intra-epithelial neoplasia, using in situ hybridization and various polymerase chain reaction techniques.
Zehbe I; Rylander E; Edlund K; Wadell G; Wilander E
Virchows Arch; 1996 Jun; 428(3):151-7. PubMed ID: 8688969
[TBL] [Abstract][Full Text] [Related]
15. Immediate histologic correlation in women with atypical squamous cells of undetermined significance cytology and positive high-risk HPV: A retrospective review of 6000 cases in a large academic women's hospital.
Zhang H; Pradhan D; Wang T; Ashman D; Matsko J; Zhao C
Cancer Cytopathol; 2020 Nov; 128(11):852-859. PubMed ID: 32639689
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
17. [Association between high risk human papillomavirus DNA load and cervical lesions in different infection status].
Li TY; Wu ZN; Jiang MY; Cui JF; Liu B; Chen F; Chen W
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):475-480. PubMed ID: 29936777
[No Abstract] [Full Text] [Related]
18. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.
Belinson JL; Hu S; Niyazi M; Pretorius RG; Wang H; Wen C; Smith JS; Li J; Taddeo FJ; Burchette RJ; Qiao YL
Int J Cancer; 2010 Sep; 127(5):1151-7. PubMed ID: 20039323
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
Castle PE; Solomon D; Schiffman M; Wheeler CM
J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
[TBL] [Abstract][Full Text] [Related]
20. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]